SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic : a double-blind, randomised, placebo-controlled trial
| dc.contributor.author | Long, Merete B. | |
| dc.contributor.author | Abo-Leyah, Hani | |
| dc.contributor.author | Giam, Yan Hui | |
| dc.contributor.author | Vadiveloo, Thenmalar | |
| dc.contributor.author | Hull, Rebecca C. | |
| dc.contributor.author | Keir, Holly R. | |
| dc.contributor.author | Pembridge, Thomas | |
| dc.contributor.author | De Lima, Daniela Alferes | |
| dc.contributor.author | Delgado, Lilia | |
| dc.contributor.author | Inglis, Sarah K. | |
| dc.contributor.author | Hughes, Chloe | |
| dc.contributor.author | Gilmour, Amy | |
| dc.contributor.author | Gierlinski, Marek | |
| dc.contributor.author | New, Benjamin J.M. | |
| dc.contributor.author | Maclennan, Graeme | |
| dc.contributor.author | Dinkova-Kostova, Albena T. | |
| dc.contributor.author | Chalmers, James D. | |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Evaluation | en |
| dc.contributor.institution | University of Aberdeen.Centre for Healthcare Randomised Trials (CHaRT) | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2024-05-06T13:05:01Z | |
| dc.date.available | 2024-05-06T13:05:01Z | |
| dc.date.issued | 2024-03 | |
| dc.description | We acknowledge the members of the STAR-COVID data monitoring committee: Aran Singanayagam (Imperial College, London, UK), Timothy Hinks (University of Oxford, Oxford, UK), Oriol Sibila (Hospital Clinic, Barcelona, Spain), Alex McConnachie (University of Glasgow, Glasgow, UK) and Petra Rauchhaus (University of Dundee, Dundee, UK). This trial was delivered by Tayside Clinical Trials Unit, a UKCRC registered clinical trials unit. Thanks to Clare Clarke, Jennifer Taylor, Angela Strachan, Heather Loftus and Jodie Strachan (Ninewells Hospital and Medical School, Dundee, UK) and Diane Cassidy (University of Dundee). We thank all study participants and their families. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 14 | |
| dc.format.extent | 748754 | |
| dc.identifier | 288797658 | |
| dc.identifier | 0248b299-5686-45d5-b448-0fa386672c30 | |
| dc.identifier | 85187909521 | |
| dc.identifier.citation | Long, M B, Abo-Leyah, H, Giam, Y H, Vadiveloo, T, Hull, R C, Keir, H R, Pembridge, T, De Lima, D A, Delgado, L, Inglis, S K, Hughes, C, Gilmour, A, Gierlinski, M, New, B J M, Maclennan, G, Dinkova-Kostova, A T & Chalmers, J D 2024, 'SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic : a double-blind, randomised, placebo-controlled trial', ERJ Open Research, vol. 10, no. 2, 00917-2023. https://doi.org/10.1183/23120541.00917-2023 | en |
| dc.identifier.doi | 10.1183/23120541.00917-2023 | |
| dc.identifier.iss | 2 | en |
| dc.identifier.issn | 2312-0541 | |
| dc.identifier.other | ORCID: /0000-0002-1039-5646/work/159077807 | |
| dc.identifier.uri | https://hdl.handle.net/2164/23405 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85187909521&partnerID=8YFLogxK | en |
| dc.identifier.vol | 10 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | ERJ Open Research | en |
| dc.subject | Pulmonary and Respiratory Medicine | en |
| dc.title | SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic : a double-blind, randomised, placebo-controlled trial | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Long_etal_ERJO_Sfx-01_in_Hospitalised_VOR.pdf
- Size:
- 731.21 KB
- Format:
- Adobe Portable Document Format
